SAN MATEO, Calif.–(BUSINESS WIRE)–#BairdConference–Model N, Inc. (NYSE: MODN), the leading provider of cloud revenue management solutions for Life Sciences and High Tech companies, today announced that Jason Blessing, president and chief executive officer, and David Barter, senior vice president and chief financial officer, will present at the following virtual investor conferences.
Live webcasts of the presentations will be accessible from the investor relations page of the Model N website at https://investor.modeln.com/.
About Model N
Model N is a leading provider of cloud revenue management solutions for Life Sciences and High Tech companies. Our software helps companies drive mission-critical business processes such as pricing, quoting, contracting, regulatory compliance, rebates and incentives. With deep industry expertise, Model N supports the complex business needs of the world’s leading brands in pharmaceutical, medical technology, semiconductor, and High Tech manufacturing across more than 120 countries, including Johnson & Johnson, AstraZeneca, Novartis, Microchip Technology and ON Semiconductor. For more information, visit www.modeln.com.
Model N® is the registered trademark of Model N, Inc. Any other company names mentioned are the property of their respective owners and are mentioned for identification purposes only.
Contacts
Investor Relations Contact:
Gwyn Lauber
Model N, Inc.
650-610-4998
investorrelations@modeln.com
Media Contact:
Laura Ruark
Bospar
laura@bospar.com
Pivotal Trial for Improving Overall Function and Quality of LifeSALT LAKE CITY--(BUSINESS WIRE)--#medicaldevices--PhotoPharmics, a pioneer…
Bill passage key to supplemental oxygen access and adequate reimbursementIRVING, TX / ACCESSWIRE / March…
GREENVILLE, SC / ACCESSWIRE / March 26, 2024 / Rymedi is proud to announce its…
NORTHAMPTON, MA / ACCESSWIRE / March 26, 2024 / Quest Diagnostics At Quest for 2…
Expanding its roster of technology leaders will enhance its ability to drive innovation and deliver…
Third-party research confirms significant impact of specialty expertise on patients’ quality of life and costs…